Robinson's Current Therapy in Equine Medicine
Kim A. Sprayberry, N. Edward Robinson
- 1,024 páginas
- English
- ePUB (apto para móviles)
- Disponible en iOS y Android
Robinson's Current Therapy in Equine Medicine
Kim A. Sprayberry, N. Edward Robinson
Información del libro
With coverage of current issues and the latest therapeutic advances, Robinson's Current Therapy in Equine Medicine, Volume 7 provides a concise, all-new reference for the management of equine disorders and conditions. Chapters emphasize the practical aspects of diagnosis and treatment and provide details for therapeutic regimens. This new volume brings you thorough coverage and authoritative advice on selected topics in areas that have seen significant advances in the last five years. Cutting-edge topics include emerging and exotic infectious diseases that may endanger horses in North America; biosecurity strategies; imaging updates; medical genetics; multimodal pain management; and regenerative, geriatric, and oncologic medicine. A logical body-system organization will save you time in finding the information you need. From well-known editors Kim Sprayberry and N. Edward Robinson, with chapters written by nearly 200 equine experts, this invaluable reference provides unparalleled guidance on the latest issues in equine medicine.
- Key topics include all-new coverage of the latest developments in imaging, biosecurity strategies for individual horse owners and owners of commercial farms and stables, diseases affecting horses at various ages, and a review of colic and other GI tract conditions.
- A recognized panel of nearly 200 expert contributors represents thriving private equine practices, referral hospitals, and academia, and provides insight on challenges, developments, and differing perspectives from around the world.
- A succinct approach is used to discuss pathophysiology and diagnosis, but therapeutics are covered in detail.
- The Current Therapy format focuses on emerging trends, treatment protocols, and diagnostic updates new to the field, providing timely information on the latest advances in equine medicine.
- A body systems organization makes it easy to find solutions for specific disorders.
- Suggested readings at the end of each chapter cite peer-reviewed articles and other sources for further research and study.
- ALL-NEW topics provide updates on infectious diseases, including herpesvirus, equine granulocytic anaplasmosis, and lawsonia infection and proliferative enteropathy; pain diagnosis and multimodal management; management of thoracic and airway trauma, imaging, endoscopy, and other diagnostic procedures for the acute abdomen; and neurologic injury.
- 212 concise, NEW chapters include both a succinct guide to diagnosis of disorders and a detailed discussion of therapy.
- NEW images demonstrate advances in various imaging techniques.
- Thoroughly updated drug appendices, including all-new coverage of drug dosages for donkeys and mules, provide a handy, quick reference for the clinical setting.
Preguntas frecuentes
Información
Table of Common Drugs and Approximate Dosages
Name of Drug | Dose | Route |
Acepromazine | 0.02-0.066 mg/kg for sedation | IV, IM, or PO |
0.033-0.055 mg/kg followed by 0.055-0.066 mg/kg butorphanol tartrate | IV | |
0.04 mg/kg followed by 0.6 mg/kg meperidine | IV | |
0.02 mg/kg q 6 to 8 hr for α-adrenoceptor blockade | IM or IV | |
Acetazolamide | 2-3 mg/kg q 6 to 12 hr | PO |
Acetylcysteine (10%) | 2-5 mL/50 kg q 6 hr | Aerosol |
10% topical solution q 1 to 4 hr | Ophthalmic | |
6 g diluted in 150 mL sterile saline | Intrauterine | |
4% solution (made by adding 150 mg acetylcysteine powder to 150 mL water). Administer 200 mL rectally through a Foley catheter with balloon inflated to make a mild seal, clamp to retain for 20 min. As an aid to dissolve disulfide bonds and aid passage of retained meconium in neonatal foals. | Rectal | |
Acetylsalicylic acid | 10-20 mg/kg q 24 hr | PO |
4-12 mg/kg q 24 hr | IV | |
Acyclovir | 5-10 mg/kg q 8 hr | PO |
3% ointment q 3 to 4 hr | Ophthalmic | |
5% ointment q 8 to 12 hr topically for treatment of sarcoid | Topical | |
Adrenocorticotrophic hormone (ACTH) | 0.26 mg q 8 to 12 hr (depot preparation) | IM |
0.125 mg/foal (tests adrenal function of premature foals) | IV | |
Albendazole | 25 mg/kg q 12 hr for 5 days for Dictyocaulus arnfieldi infection | PO |
50 mg/kg q 12 hr for 2 consecutive days for Strongylus vulgaris larvae | PO | |
4-8 mg/kg q 12 hr for 1 mo for Echinococcus spp infection | PO | |
Albuterol | 1-2 µg/kg (may n... |